REPORT ID 5374

Global Hematological Cancers Market Research Report 2017

Publish Date
21-Dec-17
Pages
110
Format
Electronic (PDF)

In this report, the global Hematological Cancers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hematological Cancers in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Hematological Cancers market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Karyopharm Therapeutics
    Johnson & Johnson
    Roche Diagnostics A/S
    AbbVie
    Novartis
    Kite Pharma
    Celgene Corporation
    Abbott Laboratories
    Beckman Coulter
    HemoCue AB
    C. R. Bard
    Siemens AG
    Sysmex
    Mindray Medical International Limited
    Bio-Rad Laboratories
    The Medicine Company
    Pharmacyclics
    Horiba
    DiagnoCure Inc.
    Astellas Pharma US
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Pharmacological Therapies
    Stem Cell Transplantation
    Surgery and Radiation Therapy
    Anemia Treatment
    Thrombosis Treatment
    Neutopenia Treatment
    Symptomatic treatment
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Epidemiology
    Pathophysiology of Leukemic Stem Cells
    Kidney Diseases
    Genetic Diseases
    Other Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Hematological Cancers Market Research Report 2017
1 Hematological Cancers Market Overview
    1.1 Product Overview and Scope of Hematological Cancers
    1.2 Hematological Cancers Segment by Type (Product Category)
        1.2.1 Global Hematological Cancers Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Hematological Cancers Production Market Share by Type (Product Category) in 2016
        1.2.3 Pharmacological Therapies
        1.2.4 Stem Cell Transplantation
        1.2.5 Surgery and Radiation Therapy
        1.2.6 Anemia Treatment
        1.2.7 Thrombosis Treatment
        1.2.8 Neutopenia Treatment
        1.2.9 Symptomatic treatment
    1.3 Global Hematological Cancers Segment by Application
        1.3.1 Hematological Cancers Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Epidemiology
        1.3.3 Pathophysiology of Leukemic Stem Cells
        1.3.4 Kidney Diseases
        1.3.5 Genetic Diseases
        1.3.6 Other Diseases
    1.4 Global Hematological Cancers Market by Region (2012-2022)
        1.4.1 Global Hematological Cancers Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Hematological Cancers (2012-2022)
        1.5.1 Global Hematological Cancers Revenue Status and Outlook (2012-2022)
        1.5.2 Global Hematological Cancers Capacity, Production Status and Outlook (2012-2022)

2 Global Hematological Cancers Market Competition by Manufacturers
    2.1 Global Hematological Cancers Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Hematological Cancers Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Hematological Cancers Production and Share by Manufacturers (2012-2017)
    2.2 Global Hematological Cancers Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Hematological Cancers Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Hematological Cancers Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Hematological Cancers Market Competitive Situation and Trends
        2.5.1 Hematological Cancers Market Concentration Rate
        2.5.2 Hematological Cancers Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Hematological Cancers Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Hematological Cancers Capacity and Market Share by Region (2012-2017)
    3.2 Global Hematological Cancers Production and Market Share by Region (2012-2017)
    3.3 Global Hematological Cancers Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Hematological Cancers Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Hematological Cancers Consumption by Region (2012-2017)
    4.2 North America Hematological Cancers Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Hematological Cancers Production, Consumption, Export, Import (2012-2017)
    4.4 China Hematological Cancers Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Hematological Cancers Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Hematological Cancers Production, Consumption, Export, Import (2012-2017)
    4.7 India Hematological Cancers Production, Consumption, Export, Import (2012-2017)

5 Global Hematological Cancers Production, Revenue (Value), Price Trend by Type
    5.1 Global Hematological Cancers Production and Market Share by Type (2012-2017)
    5.2 Global Hematological Cancers Revenue and Market Share by Type (2012-2017)
    5.3 Global Hematological Cancers Price by Type (2012-2017)
    5.4 Global Hematological Cancers Production Growth by Type (2012-2017)

6 Global Hematological Cancers Market Analysis by Application
    6.1 Global Hematological Cancers Consumption and Market Share by Application (2012-2017)
    6.2 Global Hematological Cancers Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Hematological Cancers Manufacturers Profiles/Analysis
    7.1 Karyopharm Therapeutics
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Hematological Cancers Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Karyopharm Therapeutics Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Johnson & Johnson
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Hematological Cancers Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Johnson & Johnson Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Roche Diagnostics A/S
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Hematological Cancers Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Roche Diagnostics A/S Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 AbbVie
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Hematological Cancers Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 AbbVie Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Novartis
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Hematological Cancers Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Novartis Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Kite Pharma
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Hematological Cancers Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Kite Pharma Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Celgene Corporation
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Hematological Cancers Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Celgene Corporation Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Abbott Laboratories
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Hematological Cancers Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Abbott Laboratories Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Beckman Coulter
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Hematological Cancers Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Beckman Coulter Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 HemoCue AB
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Hematological Cancers Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 HemoCue AB Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 C. R. Bard
    7.12 Siemens AG
    7.13 Sysmex
    7.14 Mindray Medical International Limited
    7.15 Bio-Rad Laboratories
    7.16 The Medicine Company
    7.17 Pharmacyclics
    7.18 Horiba
    7.19 DiagnoCure Inc.
    7.20 Astellas Pharma US

8 Hematological Cancers Manufacturing Cost Analysis
    8.1 Hematological Cancers Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Hematological Cancers

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Hematological Cancers Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Hematological Cancers Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Hematological Cancers Market Forecast (2017-2022)
    12.1 Global Hematological Cancers Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Hematological Cancers Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Hematological Cancers Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Hematological Cancers Price and Trend Forecast (2017-2022)
    12.2 Global Hematological Cancers Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Hematological Cancers Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Hematological Cancers Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Hematological Cancers Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Hematological Cancers Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Hematological Cancers Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Hematological Cancers Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Hematological Cancers Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Hematological Cancers Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer